Congress studies 'pay for delay' generics deals; Wireless and mobile tech poised to transform nursing;

> Congress has turned its beady eye on generic drugmakers, who face scrutiny over so-called "pay for delay" deals keeping generic drugs the off market. The deals involve payments from major pharmas hoping to protect the profits of their branded product. FiercePharma

> Wireless and mobile technologies are more than cool: for one thing, they can actually transform the practice of nursing, according to a recent report. FierceMobileHealthcare

> So, what do you do if you're one of the people who's laid off in the down economy? Here's some advice from a healthcare administrator who knows what he's talking about--first-hand. HospitalImpact

> New research has concluded that blood-sugar drug metformin, already a staple of diabetes care, may also help vaccinemakers improve the effectiveness of existing vaccines. FierceVaccines

And Finally... Come on now, officers, haven't you ever been tempted to duct-tape someone you didn't like? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.